BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2301 related articles for article (PubMed ID: 27151605)

  • 1. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
    Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
    JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.
    Montalescot G; Collet JP; Ecollan P; Bolognese L; Ten Berg J; Dudek D; Hamm C; Widimsky P; Tanguay JF; Goldstein P; Brown E; Miller DL; LeNarz L; Vicaut E;
    J Am Coll Cardiol; 2014 Dec; 64(24):2563-2571. PubMed ID: 25524333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
    Déry JP; Mahaffey KW; Tricoci P; White HD; Podder M; Westerhout CM; Moliterno DJ; Harrington RA; Chen E; Strony J; Van de Werf F; Ziada KM; Held C; Aylward PE; Armstrong PW; Rao SV
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):163-73. PubMed ID: 26698636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel.
    Widimsky P; Motovska Z; Bolognese L; Dudek D; Hamm C; Tanguay JF; Ten Berg J; Brown E; LeNarz L; Miller DL; Montalescot G;
    Heart; 2015 Aug; 101(15):1219-24. PubMed ID: 26060122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction.
    Silvain J; Rakowski T; Lattuca B; Liu Z; Bolognese L; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimsky P; Miller D; Portal JJ; Collet JP; Vicaut E; Montalescot G; Dudek D;
    J Am Coll Cardiol; 2019 Mar; 73(8):906-914. PubMed ID: 30819358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.
    Rashid M; Rushton CA; Kwok CS; Kinnaird T; Kontopantelis E; Olier I; Ludman P; De Belder MA; Nolan J; Mamas MA
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2258-2265. PubMed ID: 29169494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.
    Räber L; Klingenberg R; Heg D; Kelbæk H; Roffi M; Tüller D; Baumbach A; Zanchin T; Carballo D; Ostojic M; Stefanini GG; Rodondi N; von Birgelen C; Moschovitis A; Engstrøm T; Gencer B; Auer R; Meier B; Mach F; Lüscher TF; Jüni P; Matter CM; Windecker S;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1064-1074. PubMed ID: 26205445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.
    Montalescot G; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; ten Berg JM; Miller DL; Costigan TM; Goedicke J; Silvain J; Angioli P; Legutko J; Niethammer M; Motovska Z; Jakubowski JA; Cayla G; Visconti LO; Vicaut E; Widimsky P;
    N Engl J Med; 2013 Sep; 369(11):999-1010. PubMed ID: 23991622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study.
    Dudek D; Dziewierz A; Widimsky P; Bolognese L; Goldstein P; Hamm C; Tanguay JF; LeNarz L; Miller DL; Brown E; Ten Berg J; Montalescot G;
    Am Heart J; 2015 Nov; 170(5):1025-1032.e2. PubMed ID: 26542513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial.
    Gargiulo G; Ariotti S; Vranckx P; Leonardi S; Frigoli E; Ciociano N; Tumscitz C; Tomassini F; Calabrò P; Garducci S; Crimi G; Andò G; Ferrario M; Limbruno U; Cortese B; Sganzerla P; Lupi A; Russo F; Garbo R; Ausiello A; Zavalloni D; Sardella G; Esposito G; Santarelli A; Tresoldi S; Nazzaro MS; Zingarelli A; Petronio AS; Windecker S; da Costa BR; Valgimigli M
    JACC Cardiovasc Interv; 2018 Jan; 11(1):36-50. PubMed ID: 29301646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
    De Servi S; Goedicke J; Schirmer A; Widimsky P
    Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events.
    Dangoisse V; Guédès A; Gabriel L; Jamart J; Chenu P; Marchandise B; Schroeder E
    EuroIntervention; 2013 Jul; 9(3):345-52. PubMed ID: 23872649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
    Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.
    Larmore C; Effron MB; Molife C; DeKoven M; Zhu Y; Lu J; Karkare S; Lieu HD; Lee WC; Vetrovec GW
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):535-544. PubMed ID: 26577386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty.
    Alonzo A; Rigattieri S; Giovannelli F; Di Russo C; Sciahbasi A; Berni A; Volpe M
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):849-54. PubMed ID: 26104978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.
    Jolly SS; Yusuf S; Cairns J; Niemelä K; Xavier D; Widimsky P; Budaj A; Niemelä M; Valentin V; Lewis BS; Avezum A; Steg PG; Rao SV; Gao P; Afzal R; Joyner CD; Chrolavicius S; Mehta SR;
    Lancet; 2011 Apr; 377(9775):1409-20. PubMed ID: 21470671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.
    Valgimigli M; Gagnor A; Calabró P; Frigoli E; Leonardi S; Zaro T; Rubartelli P; Briguori C; Andò G; Repetto A; Limbruno U; Cortese B; Sganzerla P; Lupi A; Galli M; Colangelo S; Ierna S; Ausiello A; Presbitero P; Sardella G; Varbella F; Esposito G; Santarelli A; Tresoldi S; Nazzaro M; Zingarelli A; de Cesare N; Rigattieri S; Tosi P; Palmieri C; Brugaletta S; Rao SV; Heg D; Rothenbühler M; Vranckx P; Jüni P;
    Lancet; 2015 Jun; 385(9986):2465-76. PubMed ID: 25791214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.